- SGMO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Sangamo Therapeutics (SGMO) S-3Shelf registration
Filed: 21 Aug 01, 12:00am
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3 No. 333- ) and related Prospectus of Sangamo BioSciences, Inc. for the registration of 2,124,638 shares of its common stock and to the incorporation by reference therein of our report dated January 26, 2001, with respect to the financial statements and schedules of Sangamo BioSciences, Inc. included in its Annual Report on (Form 10-K) for the year ended December 31, 2000, filed with the Securities and Exchange Commission.
/s/ ERNST & YOUNG LLP
Palo Alto, California
August 21, 2001
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.